BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2625127)

  • 1. Dosimetry of iodoantipyrine.
    Chu RY; Ekeh S; Basmadjian G
    Eur J Nucl Med; 1989; 15(12):796-9. PubMed ID: 2625127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic.
    Cona MM; Koole M; Feng Y; Liu Y; Verbruggen A; Oyen R; Ni Y
    Int J Oncol; 2014 Mar; 44(3):819-29. PubMed ID: 24366374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease.
    Newberg AB; Wintering NA; Plössl K; Hochold J; Stabin MG; Watson M; Skovronsky D; Clark CM; Kung MP; Kung HF
    J Nucl Med; 2006 May; 47(5):748-54. PubMed ID: 16644743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of radiation dose to the embryo from nuclear medicine procedures.
    Smith EM; Warner GG
    J Nucl Med; 1976 Sep; 17(9):836-9. PubMed ID: 956898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
    DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
    Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
    Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
    Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and dosimetry of free 211At, 125I- and 131I- in rats.
    Spetz J; Rudqvist N; Forssell-Aronsson E
    Cancer Biother Radiopharm; 2013 Nov; 28(9):657-64. PubMed ID: 23789969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation dosimetry of radioiodinated thyroid hormones.
    Hays MT
    J Nucl Med; 1985 Sep; 26(9):1068-74. PubMed ID: 4032047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.
    Badger CC; Davis J; Nourigat C; Wu ZM; Hui TE; Fisher DR; Shulman H; Appelbaum FR; Eary JF; Krohn KA
    Cancer Res; 1991 Nov; 51(21):5921-8. PubMed ID: 1682038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of thyroid function in mice after various injected activities of 123I, 125I and 131I.
    Van Best JA
    Int J Radiat Biol Relat Stud Phys Chem Med; 1982 Nov; 42(5):545-57. PubMed ID: 6984036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
    Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
    Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects.
    Seibyl JP; Wallace E; Smith EO; Stabin M; Baldwin RM; Zoghbi S; Zea-Ponce Y; Gao Y; Zhang WY; Neumeyer JL
    J Nucl Med; 1994 May; 35(5):764-70. PubMed ID: 8176456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
    Newberg AB; Plössl K; Mozley PD; Stubbs JB; Wintering N; Udeshi M; Alavi A; Kauppinen T; Kung HF
    J Nucl Med; 2004 May; 45(5):834-41. PubMed ID: 15136634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
    Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
    Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
    Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography.
    Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR
    Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approximate distribution of dose among foetal organs for radioiodine uptake via placenta transfer.
    Millard RK; Saunders M; Palmer AM; Preece AW
    Phys Med Biol; 2001 Nov; 46(11):2773-83. PubMed ID: 11720346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results.
    Kauppinen TA; Bergström KA; Heikman P; Hiltunen J; Ahonen AK
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):132-6. PubMed ID: 12483421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for better methods to determine release criteria for patients administered radioactive material.
    Sparks RB; Siegel JA; Wahl RL
    Health Phys; 1998 Oct; 75(4):385-8. PubMed ID: 9753361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung water measurements with iodo-antipyrine.
    Chu RY; Carlile PV; Gray BA; Allen EW; Basmadjian G; Myers J
    Eur J Nucl Med; 1988; 14(11):538-41. PubMed ID: 3208784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.